80.89
전일 마감가:
$79.67
열려 있는:
$79.88
하루 거래량:
438.16K
Relative Volume:
0.88
시가총액:
$5.39B
수익:
-
순이익/손실:
$-224.29M
주가수익비율:
-20.74
EPS:
-3.9
순현금흐름:
$-185.06M
1주 성능:
+5.63%
1개월 성능:
+2.89%
6개월 성능:
+12.36%
1년 성능:
-4.79%
Nuvalent Inc Stock (NUVL) Company Profile
명칭
Nuvalent Inc
전화
508-446-2272
주소
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
NUVL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NUVL
Nuvalent Inc
|
80.89 | 5.74B | 0 | -224.29M | -185.06M | -3.90 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-09-04 | 재개 | Guggenheim | Buy |
2025-09-03 | 개시 | Raymond James | Outperform |
2025-08-19 | 개시 | Piper Sandler | Overweight |
2025-03-14 | 업그레이드 | UBS | Neutral → Buy |
2024-12-30 | 개시 | H.C. Wainwright | Buy |
2024-10-24 | 개시 | UBS | Neutral |
2024-08-29 | 개시 | Barclays | Overweight |
2024-04-17 | 개시 | Jefferies | Buy |
2024-04-01 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2024-02-28 | 재개 | Guggenheim | Buy |
2024-02-23 | 개시 | Robert W. Baird | Outperform |
2023-09-27 | 개시 | Stifel | Buy |
2023-08-08 | 개시 | SVB Securities | Market Perform |
2023-07-24 | 개시 | Guggenheim | Buy |
2023-01-18 | 개시 | Wedbush | Outperform |
2022-06-24 | 개시 | BMO Capital Markets | Outperform |
모두보기
Nuvalent Inc 주식(NUVL)의 최신 뉴스
Can momentum traders help lift Nuvalent Inc.2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
When is the best time to exit Nuvalent Inc.Portfolio Update Report & Advanced Swing Trade Entry Alerts - Newser
Is Nuvalent Inc. stock forming a triangle pattern2025 Market Overview & Verified Technical Trade Signals - خودرو بانک
Is now the right time to enter Nuvalent Inc.Quarterly Performance Summary & Technical Confirmation Trade Alerts - خودرو بانک
Can Nuvalent Inc. grow without external fundingJuly 2025 Levels & Real-Time Market Trend Scan - خودرو بانک
Market reaction to Nuvalent Inc.’s recent newsWeekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Best data tools to analyze Nuvalent Inc. stockJuly 2025 Update & Daily Entry Point Alerts - Newser
Is Nuvalent Inc.’s ROIC above industry averageJuly 2025 Big Picture & Safe Swing Trade Setups - خودرو بانک
Should I buy Nuvalent Inc. stock now2025 Institutional Moves & Low Risk High Reward Ideas - خودرو بانک
Can Nuvalent Inc. navigate macro headwindsInflation Watch & Verified Short-Term Plans - 더경남뉴스
Inflation Data: Can Nuvalent Inc. navigate macro headwindsJuly 2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - khodrobank.com
How moving averages guide Nuvalent Inc. tradingQuarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
Is Nuvalent Inc. stock entering bullish territory2025 Valuation Update & Daily Chart Pattern Signal Reports - Newser
Nuvalent Inc. stock outlook for YEARMarket Trend Review & High Conviction Buy Zone Alerts - Newser
BostInnoCoconut water out, cactus water in | Nuvalent's $166M Nasdaq debut - The Business Journals
Can Nuvalent Inc. continue delivering strong returnsQuarterly Portfolio Report & Safe Capital Investment Plans - خودرو بانک
Guggenheim initiates coverage on Nuvalent stock with Buy rating By Investing.com - Investing.com Nigeria
How is Nuvalent Inc. managing supply chain issuesWeekly Stock Summary & Accurate Trade Setup Notifications - خودرو بانک
Can Nuvalent Inc. rally from current levelsIndex Update & AI Driven Stock Reports - Newser
Momentum divergence signals in Nuvalent Inc. chart2025 Market Outlook & Daily Stock Momentum Reports - Newser
Analyzing Nuvalent Inc. with risk reward ratio chartsTrend Reversal & Capital Protection Trade Alerts - Newser
Top chart patterns to watch in Nuvalent Inc.July 2025 Gainers & Consistent Income Trade Ideas - Newser
Piper Sandler Initiates Nuvalent (NUVL) Amid Key Cancer Drug Catalysts - MSN
Travel Stocks: Will Nuvalent Inc. benefit from geopolitical trendsJuly 2025 Big Picture & Real-Time Stock Entry Alerts - خودرو بانک
How to build a custom watchlist for Nuvalent Inc.2025 Volume Leaders & High Conviction Investment Ideas - Newser
Advanced analytics toolkit walkthrough for Nuvalent Inc.Weekly Investment Summary & Free Real-Time Volume Trigger Notifications - Newser
Nuvalent:Raymond James initiates coverage with Outperform rating, PT $105. - AInvest
Chart based exit strategy for Nuvalent Inc.Earnings Summary Report & Daily Oversold Stock Bounce Ideas - Newser
Using portfolio simulators with Nuvalent Inc. includedWeekly Trend Recap & Capital Efficient Trade Techniques - Newser
Nuvalent, Inc. shares rise 1.30% premarket after Raymond James initiates coverage with an Outperform rating. - AInvest
Raymond James Initiates Nuvalent at Outperform With $105 Price Target - MarketScreener
Can technical indicators confirm Nuvalent Inc.’s reversalGold Moves & Fast Exit Strategy with Risk Control - Newser
Is Nuvalent Inc. stock a value trap2025 Bull vs Bear & Daily Growth Stock Tips - khodrobank.com
How institutional ownership impacts Nuvalent Inc. stockWeekly Gains Report & Stepwise Entry/Exit Trade Alerts - Newser
Is Nuvalent Inc. stock overvalued or fairly pricedVolume Spike & Weekly Momentum Picks - خودرو بانک
How to use a screener to detect Nuvalent Inc. breakoutsInsider Selling & Fast Gain Swing Alerts - Newser
Nuvalent’s (NUVL) Near-Term Catalysts and Precision Oncology Potential: A Case for Undervalued Upside - AInvest
What does recent volatility data suggest for Nuvalent Inc.2025 Support & Resistance & Low Risk Entry Point Guides - Newser
Nuvalent Inc (NUVL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nuvalent Inc 주식 (NUVL) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Noci Darlene | Chief Development Officer |
Aug 25 '25 |
Option Exercise |
27.85 |
4,000 |
111,400 |
52,034 |
Noci Darlene | Chief Development Officer |
Aug 25 '25 |
Sale |
74.62 |
4,000 |
298,489 |
48,034 |
Porter James Richard | President and CEO |
Aug 15 '25 |
Option Exercise |
18.93 |
27,000 |
511,110 |
276,062 |
Porter James Richard | President and CEO |
Aug 15 '25 |
Sale |
75.42 |
27,000 |
2,036,325 |
249,062 |
Pelish Henry E. | Chief Scientific Officer |
Aug 07 '25 |
Option Exercise |
27.71 |
5,500 |
152,415 |
66,456 |
Pelish Henry E. | Chief Scientific Officer |
Aug 07 '25 |
Sale |
74.85 |
5,500 |
411,675 |
60,956 |
Noci Darlene | Chief Development Officer |
Jul 30 '25 |
Option Exercise |
27.85 |
4,000 |
111,400 |
52,034 |
Noci Darlene | Chief Development Officer |
Jul 30 '25 |
Sale |
80.36 |
4,000 |
321,440 |
48,034 |
자본화:
|
볼륨(24시간):